Specialized company in the development of new small molecule drugs
targeting mostly oncology and neurology diseases using FBDD and artificial intelligence with pharmaceutical experts.
developing new treatments through a cancer disease pipeline that can be available a lot of data and verification systems compared to other diseases.
Also, the cancer pipeline has been used to advance “Seamless Drug Discovery”.